Evidence map›Paper›PMID 35899801›Full record

ArticleAdvanced healthcare materials2022

The Modular µSiM: A Mass Produced, Rapidly Assembled, and Reconfigurable Platform for the Study of Barrier Tissue Models In Vitro.

Molly C McCloskey, Pelin Kasap, S Danial Ahmad, Shiuan-Haur Su, Kaihua Chen, Mehran Mansouri, Natalie Ramesh, Hideaki Nishihara, Yury Belyaev, Vinay V Abhyankar and 8 more

Open access · greenAbstract read
In one paragraph

Article in Advanced healthcare materials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 3 countries.

Molly C McCloskeyDepartment of Biomedical Engineering, University of Rochester, Rochester, NY, 14627, USA.ORCID 0000-0002-5237-8422
Pelin KasapTheodor Kocher Institute, University of Bern, Bern, 3012, Switzerland.ORCID 0000-0003-3423-7359
S Danial AhmadDepartment of Biomedical Engineering, University of Rochester, Rochester, NY, 14627, USA.ORCID 0000-0003-3956-0139
Shiuan-Haur SuDepartment of Mechanical Engineering, University of Michigan, Ann Arbor, MI, 48109, USA.ORCID 0000-0002-8956-3533
Kaihua ChenDepartment of Biomedical Engineering, University of Rochester, Rochester, NY, 14627, USA.
Mehran MansouriDepartment of Biomedical Engineering, Rochester Institute of Technology, Rochester, NY, 14623, USA.ORCID 0000-0002-2949-1857
Natalie RameshDepartment of Biomedical Engineering, University of Rochester, Rochester, NY, 14627, USA.
Hideaki NishiharaTheodor Kocher Institute, University of Bern, Bern, 3012, Switzerland.ORCID 0000-0002-2990-835X
Yury BelyaevMicroscopy Imaging Center, University of Bern, Bern, 3012, Switzerland.
Vinay V AbhyankarDepartment of Biomedical Engineering, Rochester Institute of Technology, Rochester, NY, 14623, USA.
Stefano BegoloALine Inc., Signal Hill, CA, 90755, USA.ORCID 0000-0002-1361-8200
Benjamin H SingerDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.ORCID 0000-0002-4721-6920
Kevin F WebbOptics & Photonics Research Group, Department of Electrical and Electronic Engineering, University of Nottingham, Nottingham, NG7 2RD, UK.ORCID 0000-0002-0858-304X
Katsuo KurabayashiDepartment of Mechanical Engineering, University of Michigan, Ann Arbor, MI, 48109, USA.ORCID 0000-0002-9613-3590
Jonathan FlaxDepartment of Biomedical Engineering, University of Rochester, Rochester, NY, 14627, USA.
Richard E WaughDepartment of Biomedical Engineering, University of Rochester, Rochester, NY, 14627, USA.ORCID 0000-0003-2084-5740
Britta EngelhardtTheodor Kocher Institute, University of Bern, Bern, 3012, Switzerland.ORCID 0000-0003-3059-9846
James L McGrathDepartment of Biomedical Engineering, University of Rochester, Rochester, NY, 14627, USA.ORCID 0000-0003-2017-8335
University of Rochester · USUniversity of Bern · CHUniversity of Michigan · USRochester Institute of Technology · USUniversity of Nottingham · GB

Funding

VISUAL INDICES OF NEUROTOXICITYP30ES001247 · NIEHS · UNIVERSITY OF ROCHESTER · PI Martha Susiarjo · 1985 to 2026
$42.8M
A microphysiological system of tendon inflammation and fibrosis for drug screening and efficacy testingUH3TR003281 · NCATS · UNIVERSITY OF ROCHESTER · PI AWAD, HANI A, MCGRATH, JAMES L · 2022 to 2024
$2.2M
A microphysiological system of tendon inflammation and fibrosis for drug screening and efficacy testing: MPS Database EngagementUG3TR003281 · NCATS · UNIVERSITY OF ROCHESTER · PI AWAD, HANI A, MCGRATH, JAMES L · 2020 to 2021
$1.6M
The µSiM-hNVU - a human BBB platform for the study of brain injury mechanisms during systemic infectionR61HL154249 · NHLBI · UNIVERSITY OF ROCHESTER · PI ENGELHARDT, BRITTA, GABORSKI, THOMAS R · 2020 to 2021
$1.2M
Biotechnology and Biological Sciences Research Council BB/K010212/1Biotechnology and Biological Sciences Research Council BB/M027848/1NCATS NIH HHS UG3 TR003281NCATS NIH HHS UH3 TR003281NHLBI NIH HHS R61 HL154249NIEHS NIH HHS P30 ES001247
6 · The paper itself

Abstract

Advanced in vitro tissue chip models can reduce and replace animal experimentation and may eventually support "on-chip" clinical trials. To realize this potential, however, tissue chip platforms must be both mass-produced and reconfigurable to allow for customized design. To address these unmet needs, an extension of the µSiM (microdevice featuring a silicon-nitride membrane) platform is introduced. The modular µSiM (m-µSiM) uses mass-produced components to enable rapid assembly and reconfiguration by laboratories without knowledge of microfabrication. The utility of the m-µSiM is demonstrated by establishing an hiPSC-derived blood-brain barrier (BBB) in bioengineering and nonengineering, brain barriers focused laboratories. In situ and sampling-based assays of small molecule diffusion are developed and validated as a measure of barrier function. BBB properties show excellent interlaboratory agreement and match expectations from literature, validating the m-µSiM as a platform for barrier models and demonstrating successful dissemination of components and protocols. The ability to quickly reconfigure the m-µSiM for coculture and immune cell transmigration studies through addition of accessories and/or quick exchange of components is then demonstrated. Because the development of modified components and accessories is easily achieved, custom designs of the m-µSiM shall be accessible to any laboratory desiring a barrier-style tissue chip platform.

Indexed as

Induced Pluripotent Stem CellsSiliconAnimalsBiological TransportBlood-Brain BarrierCoculture TechniquesSiliconblood-brain barriersmembranesmodularitytissue chipsvascular barriers

Identifiers

PMID35899801
PMCPMC9580267
OpenAlexW4288436719

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.